Lungpacer Medical wins FDA premarket approval for AeroPace neurostim system

Retrieved on: 2024-12-07 07:51:19

Tags for this article:

Click the tags to see associated articles and topics

Lungpacer Medical wins FDA premarket approval for AeroPace neurostim system. View article details on hiswai:

Excerpt

MEDTECH 100 Stock INDEX. Medtech 100 logo. Market Summary > Current Price. $79.94. December 4, 2024 at 12:10 PM PST. The MedTech 100 is a financial ...

Article found on: www.massdevice.com

View Original Article